Bio-Rad Laboratories, Inc. (BIO)

Last Closing Price: 227.61 (2025-05-29)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Bio-Rad Laboratories, Inc. (BIO) had Net Income of $64.00M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$585.40M
Net Income
$64.00M
$279.40M
$306.00M
$561.70M
$23.70M
$59.70M
$83.40M
$51.60M
$64.00M
$64.00M
$64.00M
$24.80M
$23.70M
$23.70M
27.94M
27.95M
$2.29
$2.29
Balance Sheet Financials
$3.04B
$528.50M
$6.49B
$9.53B
$506.60M
$1.20B
$2.34B
$2.85B
$6.68B
$5.97B
$6.68B
27.63M
Cash Flow Statement Financials
$129.90M
$2.90M
$-97.70M
$489.80M
$523.10M
$33.30M
--
--
--
Fundamental Metrics & Ratios
5.99
--
--
0.15
0.18
52.27%
4.05%
4.05%
--
14.25%
10.93%
$95.50M
--
--
--
0.06
0.35
1.38
65.29
0.96%
1.07%
0.67%
0.81%
$241.72
$3.42
$4.65